Loading
Hospital-at-home programmes deliver intravenous antibiotics, fluids, monitoring and daily nurse and physician visits in the patient's home, with equivalent or better outcomes and lower costs in general medicine. Extending them to low-risk fever after chemotherapy and dehydration, with payer recognition, would keep older cancer patients out of hospital beds, where they are most at risk of harm.
Hospital-at-home programmes deliver acute-level care (IV antibiotics, fluids, monitoring, daily nurse and physician oversight) in the patient's home and have shown equivalent or better outcomes, fewer complications, and lower costs in general medicine. Oncology-specific programmes (such as Huntsman at Home) report reduced admissions and emergency visits. Expanding the model to defined oncology conditions, with payer recognition, would reduce hospitalisation, which is particularly harmful for older patients.
Shares Older and multimorbid patients are excluded and undertreated, Fragmented care and guideline gaps, Toxicity and quality of life are undervalued.
Shares Older and multimorbid patients are excluded and undertreated, Fragmented care and guideline gaps.
Shares Older and multimorbid patients are excluded and undertreated, Fragmented care and guideline gaps.
Shares Older and multimorbid patients are excluded and undertreated, Fragmented care and guideline gaps.
Shares Fragmented care and guideline gaps, Toxicity and quality of life are undervalued.
Shares Fragmented care and guideline gaps, Toxicity and quality of life are undervalued.
Shares Older and multimorbid patients are excluded and undertreated, Toxicity and quality of life are undervalued.
Shares Older and multimorbid patients are excluded and undertreated, Toxicity and quality of life are undervalued.